Poorly absorbed antibiotics for the treatment of traveler's diarrhea

David N. Taylor

Research output: Contribution to journalArticle

Abstract

This article describes the use of poorly absorbed antibiotics for the treatment of traveler's diarrhea. Poorly absorbed oral antibiotics can deliver high concentrations of drug to the site of enteric infection with minimal risk of systemic adverse effects, toxicity, and drug interactions. Compared with systemically absorbed oral antibiotics, poorly absorbed oral antibiotics may be less associated with the pressure that leads to the development of bacterial resistance, because they do not affect bacteria outside the gastrointestinal tract. In clinical studies, poorly absorbed oral antibiotics, including aztreonam, bicozamycin, and rifaximin, were more effective than and as well tolerated as placebo; in particular, rifaximin was as effective as oral ciprofloxacin in reducing the duration of illness in traveler's diarrhea. More research is warranted to delineate the effects of poorly absorbed antibiotics in invasive infection and to assess the potential for the development of bacterial resistance.

Original languageEnglish (US)
JournalClinical Infectious Diseases
Volume41
Issue numberSUPPL. 11
DOIs
StatePublished - Dec 1 2005

Fingerprint

Diarrhea
Anti-Bacterial Agents
rifaximin
Therapeutics
Aztreonam
Ciprofloxacin
Infection
Drug Interactions
Gastrointestinal Tract
Placebos
Bacteria
Pressure
Research
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Immunology

Cite this

Poorly absorbed antibiotics for the treatment of traveler's diarrhea. / Taylor, David N.

In: Clinical Infectious Diseases, Vol. 41, No. SUPPL. 11, 01.12.2005.

Research output: Contribution to journalArticle

@article{82e966c46ef743cbb7e32c6a791ac21c,
title = "Poorly absorbed antibiotics for the treatment of traveler's diarrhea",
abstract = "This article describes the use of poorly absorbed antibiotics for the treatment of traveler's diarrhea. Poorly absorbed oral antibiotics can deliver high concentrations of drug to the site of enteric infection with minimal risk of systemic adverse effects, toxicity, and drug interactions. Compared with systemically absorbed oral antibiotics, poorly absorbed oral antibiotics may be less associated with the pressure that leads to the development of bacterial resistance, because they do not affect bacteria outside the gastrointestinal tract. In clinical studies, poorly absorbed oral antibiotics, including aztreonam, bicozamycin, and rifaximin, were more effective than and as well tolerated as placebo; in particular, rifaximin was as effective as oral ciprofloxacin in reducing the duration of illness in traveler's diarrhea. More research is warranted to delineate the effects of poorly absorbed antibiotics in invasive infection and to assess the potential for the development of bacterial resistance.",
author = "Taylor, {David N.}",
year = "2005",
month = "12",
day = "1",
doi = "10.1086/432953",
language = "English (US)",
volume = "41",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "SUPPL. 11",

}

TY - JOUR

T1 - Poorly absorbed antibiotics for the treatment of traveler's diarrhea

AU - Taylor, David N.

PY - 2005/12/1

Y1 - 2005/12/1

N2 - This article describes the use of poorly absorbed antibiotics for the treatment of traveler's diarrhea. Poorly absorbed oral antibiotics can deliver high concentrations of drug to the site of enteric infection with minimal risk of systemic adverse effects, toxicity, and drug interactions. Compared with systemically absorbed oral antibiotics, poorly absorbed oral antibiotics may be less associated with the pressure that leads to the development of bacterial resistance, because they do not affect bacteria outside the gastrointestinal tract. In clinical studies, poorly absorbed oral antibiotics, including aztreonam, bicozamycin, and rifaximin, were more effective than and as well tolerated as placebo; in particular, rifaximin was as effective as oral ciprofloxacin in reducing the duration of illness in traveler's diarrhea. More research is warranted to delineate the effects of poorly absorbed antibiotics in invasive infection and to assess the potential for the development of bacterial resistance.

AB - This article describes the use of poorly absorbed antibiotics for the treatment of traveler's diarrhea. Poorly absorbed oral antibiotics can deliver high concentrations of drug to the site of enteric infection with minimal risk of systemic adverse effects, toxicity, and drug interactions. Compared with systemically absorbed oral antibiotics, poorly absorbed oral antibiotics may be less associated with the pressure that leads to the development of bacterial resistance, because they do not affect bacteria outside the gastrointestinal tract. In clinical studies, poorly absorbed oral antibiotics, including aztreonam, bicozamycin, and rifaximin, were more effective than and as well tolerated as placebo; in particular, rifaximin was as effective as oral ciprofloxacin in reducing the duration of illness in traveler's diarrhea. More research is warranted to delineate the effects of poorly absorbed antibiotics in invasive infection and to assess the potential for the development of bacterial resistance.

UR - http://www.scopus.com/inward/record.url?scp=28044470494&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28044470494&partnerID=8YFLogxK

U2 - 10.1086/432953

DO - 10.1086/432953

M3 - Article

C2 - 16267720

AN - SCOPUS:28044470494

VL - 41

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - SUPPL. 11

ER -